We caught up last week with Russ Lebovitz, formerly of fullerene-based drug developer C Sixty, and Virginia Dadey of Arrowhead Research, which acquired C Sixty’s IP portfolio in its acquisition...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)